选择语言

Monoclonal Anti-Human CD28 Antibody, premium grade

  • GMP version GMP-MC2824 is now available for seamless transition.
用户评价
货号-规格
价格
Qty.
CD8-M120b-500ug
¥865.00
CD8-M120b-1mg (500ug X 2)
¥1385.00
合计0件 产品金额¥ 0

产品详情

  • 抗体来源(Source)

    Monoclonal Anti-Human CD28 Antibody, premium grade (CD8-M120b) is recombinantly produced from human 293 cells (HEK293).

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
    GMP-MC2824 is the GMP version of this CD8-M120b. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stag to later clinical phases.

  • 亚型(Isotype)

    Mouse IgG1 | Mouse Kappa

  • 偶联(Conjugate)

    Unconjugated

  • 特异性(Specificity)

    This product is a specific antibody specifically reacts with CD28.

  • 内毒素(Endotoxin)

    Less than 0.002 EU per μg by the LAL method.

  • 蛋白A残留(Protein A)

    5 ppm of protein tested by ELISA.

  • 宿主蛋白残留(Host Cell Protein)

    0.5 ng/μg of protein tested by ELISA.

  • 宿主核酸残留(Host Cell DNA)

    0.02 ng/μg of protein tested by qPCR.

  • 纯度(Purity)

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • 无菌(Sterility)

    Negative

  • 支原体(Mycoplasma)

    Negative.

  • 制剂(Formulation)

    Supplied as 0.2 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 运输(Shipping)

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • 存储(Storage)

    For long term storage, the product should be stored at liquid state at -70°C.

    This product is stable after storage at:

    1. 2-8°C for 12 months under sterile condition;
    2. -70°C for 24 months.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

产品展示

  • 电泳(SDS-PAGE)

    CD28 SDS-PAGE

    Monoclonal Anti-Human CD28 Antibody, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • SEC-MALS

    CD28 SEC-MALS

    The purity of Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) is more than 95% and the molecular weight of this protein is around 140-160 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-CELL BASE

     CD28 CELL

    Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) stimulates secretion of IL-2 by PBMC stimulated with 4 ng/mL Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3), premium grade (Cat. No. CDE-M120a). The typically EC50 for this effect is 2.03 ng/mL (QC tested).

    Protocol
  •  CD28 CELL

    The cell activity of Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) is 3.7 times better than competitor.

    Protocol
  • 稳定性(Stability)

     CD28 STABILITY

    The Cell based assay shows batch-to-batch consistency between Acro's GMP and PG CD28 Antibody.

  • 活性(Bioactivity)-ELISA

     CD28 ELISA

    Immobilized Human / Cynomolgus / Rhesus macaque CD28, His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) with a linear range of 0.098-1.563 ng/mL (QC tested).

    Protocol

用户评价
发表评论

背景介绍

T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.

前沿进展

 
药物研发进展
  • 英文全称:

    T-cell-specific surface glycoprotein CD28

  • 中文全称:

    T细胞特异性表面糖蛋白CD28

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    25 详情

  • 最高研发阶段:

    临床二期

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍